Newsfeeds - Spark Newswire

2 minute read

New Study Published In The American Journal Of Pathology Suggests Obeticholic Acid (OCA) May Improve Cognitive Impairment Associated With Cholestatic Liver Disease

Today, 11:53 AM

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, is pleased to share

ICPT

1 minute read

Analyst Ratings

Analyst Ratings for Intercept Pharmaceuticals

By Benzinga Insights

Today, 11:53 AM

Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter: Bullish Somewhat Bullish Indifferent…

ICPT

1 minute read

HC Wainwright & Co. Maintains Neutral on Intercept Pharmaceuticals, Lowers Price Target to $14

By Benzinga Newsdesk

Today, 11:53 AM

HC Wainwright & Co. analyst Ed Arce maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral and lowers the price target from $16 to $14.

ICPT

3 minute read

Reported Late Monday, Intercept Announces Development Program For Next-Generation FXR Agonist INT-787 In Severe Alcohol-Associated Hepatitis

By Benzinga Newsdesk

Today, 11:53 AM

First-in-human data shared at The Liver Meeting® 2022 supported a favorable safety and tolerability profile for INT-787 in healthy adults Company announces severe alcohol-associated hepatitis (sAH), a

ICPT

2 minute read

Analyst Ratings

What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals

By Benzinga Insights

Today, 11:53 AM

Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter:

ICPT

1 minute read

Raymond James Maintains Outperform on Intercept Pharmaceuticals, Lowers Price Target to $27

By Benzinga Newsdesk

Today, 11:53 AM

Raymond James analyst Steven Seedhouse maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Outperform and lowers the price target from $28 to $27.

ICPT

3 minute read

Gartner, Sony, Uber And Other Big Gainers From Tuesday

By Lisa Levin

Today, 11:53 AM

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

ABMD

1 minute read

Earnings

Earnings Outlook For Intercept Pharmaceuticals

By Benzinga Insights

Today, 11:53 AM

Intercept Pharmaceuticals (NASDAQ:ICPT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that Intercept Pharmaceuticals will report an earnings per share (EPS) of $4.61.

ICPT